Cellexus is a Supporter of Targeting Phage Therapy 2024



Cellexus is supporting the 7th World Conference Targeting Phage Therapy, scheduled on June 20-21 in Malta.

Who are Cellexus?

Cellexus International is a pioneering Scottish company specialized in manufacturing a range of bioreactors called the CellMaker. The CellMaker series stands out as the only single-use, purely airlift bioreactors available on the market today. The CellMaker offers efficient yet gentle mixing, allowing for easy scaling from 1.5L to 50L working volumes within a GMP-compliant system.

About CellMaker

Designed and optimised for various applications and cell types, the CellMaker systems utilize pure airlift technology to ensure efficient aeration while eliminating shear stress typically caused by impellers. This feature enables the production of clinical-grade biologics, ranging from viral vectors to phage therapies.

The single-use aspect of the CellMaker system not only streamlines operations, but also significantly reduces the economic and environmental impact of biologics manufacturing. By eliminating the need for cleaning and certifying reusable vessels, downtime is minimised, and resources such as energy, water, and chemicals are conserved.

How to collaborate with Cellexus?

Cellexus collaborates with academia and industry worldwide, offering customizable CellMaker systems tailored to meet specific process requirements while ensuring cost-effectiveness.

visit website: https://cellexus.com/

Targeting Phage Therapy 2024
7th World Conference
June 20-21, 2024 – Corinthia Palace, Malta